Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim in South African Infants [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of the Pentaxim vaccine in South African infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. [Phase 3]
A Phase 3 study comparing PENTAXIM with TETRAXIM when co-administered with ACTHIB in South Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Pentaxim given as three-dose primary vaccination with an 18-month booster.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children
A completed post-marketing safety study evaluating GSK's Poliorix (inactivated poliovirus vaccine) in Korean children to monitor safety.
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
A clinical trial update reports antibody persistence in healthy children after primary and booster vaccination with DTaP-IPV-Hep B-PRP-T com…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Pentavalent DTaP-Hep B-IPV [Phase 2]
Phase 2 trial of the pentavalent DTaP-Hep B-IPV vaccine has completed, evaluating protection against diphtheria, hepatitis B, poliomyelitis,…
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age [Phase 4]
Phase 4 study assessing immunogenicity and safety of a TETRAXIM booster given to children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® [Phase 2]
A Phase 2 trial evaluated concomitant administration of Menactra with a fifth dose of DAPTACEL in children aged 4 to 6 years. The study has …
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine [Phase 4]
Phase 4 post-marketing evaluation of adverse reactions following receipt of the recommended adolescent pertussis vaccine; sponsor is Sanofi …
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety and Immune Response of Different Pediatric Combination Vaccines. [Phase 3]
Phase 3 clinical trial update reporting safety and immune response of pediatric combination vaccines targeting diphtheria, poliomyelitis, an…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
A completed clinical trial update reporting safety results from a retrospective survey of a fourth dose of Pentacel in children.
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ [Phase 3]
Phase 3 study evaluating whether Pneumococcal Conjugate Vaccine (PCV) affects the immunogenicity of Pentacel; results were completed and pos…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED) [Phase 3]
Phase 3 trial evaluating concomitant administration of Gardasil with a combined diphtheria, tetanus, pertussis and poliomyelitis vaccine in …
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains [Phase 1]
Status update on a Phase 1 clinical trial protocol for an inactivated poliomyelitis vaccine derived from Sabin strains; the study has comple…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ [Phase 4]
Phase 4 study assessing a fifth dose of DAPTACEL in 4- to 6-year-olds previously immunized with PENTACEL. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-08-10Clinical Trial Update: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children [Phase 4]
Phase 4 study of a new formulation of the DTPa-HBV-IPV/Hib vaccine as a booster in children aged 18-23 months; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update of a pneumococcal vaccine booster in healthy children 11-18 months previously primed with the same vaccines; s…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of "Post-Polio Syndrome"
This update notes a completed clinical trial investigating post-polio syndrome conducted under the National Institute of Neurological Disord…
-
CLINICAL_TRIALS trial_result · 2007-08-09Clinical Trial Update: Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine [Phase 4]
A Phase 4 trial assessing the immunogenicity and safety of a fifth booster dose of the diphtheria-tetanus-pertussis-polio vaccine. The study…